Interventions for hypertension: latest developments

Session comprising selected EuroPCR 2026 abstract submissions

Moderators: M. Oberhoff, F. Sharif

Speakers: K. Fengler, C. F. Vigo, R. Schmieder, F. Mahfoud, F. L. Ribichini, I. J. Nunez Gil

Summary

This session reviews the latest developments in interventional treatments for hypertension, focusing on renal denervation (RDN) technologies and clinical outcomes. It includes comparative procedural data from global registries and studies, novel computational assessments, and applications in specific patient populations such as those with polycystic kidney disease or sympathetic dysautonomia. The session highlights safety, efficacy, and evolving strategies to transform hypertension management.

Presentations available when logged in:

Comparative procedural characteristics from the Global Paradise System registry and RADIANCE studies
Preliminary validation of angiography-based computational assessment of coronary physiology in renal denervation
Outcomes after RDN in patients with prior cardiovascular events: Global SYMPLICITY Registry DEFINE
Transforming severe hypertension: outcomes after renal denervation in the Global SYMPLICITY Registry
RANSOM: safety and efficacy of renal denervation in patients with severe sympathetic dysautonomia

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Interventions for hypertension: latest developments

Session comprising selected EuroPCR 2026 abstract submissions

Log in or create account for free